{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:21:04Z","timestamp":1790774464534,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A20776"],"award-info":[{"award-number":["A20776"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Foundation","award":["23-14-00134"],"award-info":[{"award-number":["23-14-00134"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>PRMT5 is expressed at high levels in many cancers, where it regulates diverse cellular pathways that contribute to oncogenesis. Here, we have defined a new role for PRMT5 in regulating and coordinating the interplay between the innate and adaptive immune response. This occurs, in part, through the influence of PRMT5 and E2F1 on RNA splicing and the presence of retained introns (RIs). We found that RIs have a propensity to form double-stranded RNAs that contribute to the innate response. Furthermore, many RIs contain non-canonical open-reading frames (ncORFs), which can be translated and then processed into small peptides that assemble with the MHC class I complex. Significantly, RI-derived peptides are highly immunogenic and, as a murine cancer vaccine, carrying a string of antigenic RI peptides, delayed tumour growth and enhanced survival. RIs are present in human tumour cells, and we identified T lymphocytes in human cancer patients, with antigen specificity for RI-derived peptides, that killed human tumour cells in vitro. Regulating intron retention thus offers a new therapeutic approach to enhance tumour immunogenicity.<\/jats:p>","DOI":"10.1038\/s44321-026-00499-1","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:55:28Z","timestamp":1786985728000},"page":"3677-3703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PRMT5-mediated intron retention triggers innate and adaptive immunity against cancer"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6188-8803","authenticated-orcid":false,"given":"Wiktoria","family":"Blaszczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-2028","authenticated-orcid":false,"given":"Wojciech","family":"Barczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5047-5455","authenticated-orcid":false,"given":"Chuyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-403X","authenticated-orcid":false,"given":"Garret","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nicastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-6924","authenticated-orcid":false,"given":"Claire","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9353-9173","authenticated-orcid":false,"given":"Anastasia","family":"Samsonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-5297","authenticated-orcid":false,"given":"Alexander","family":"Kanapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ternette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-9161","authenticated-orcid":false,"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-3736","authenticated-orcid":false,"given":"Nicholas B","family":"La Thangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ccell.2024.12.008","volume":"43","author":"A Acha-Sagredo","year":"2025","unstructured":"Acha-Sagredo A, Andrei P, Clayton K, Taggart E, Antoniotti C, Woodman CA, Afrache H, Fourny C, Armero M, Moinudeen HK et al (2025) A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer. Cancer Cell 43:292\u2013307.e297","journal-title":"Cancer Cell"},{"key":"499_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-3-11","volume":"3","author":"S Adams","year":"2005","unstructured":"Adams S, Robbins FM, Chen D, Wagage D, Holbeck SL, Morse HC 3rd, Stroncek D, Marincola FM (2005) HLA class I and II genotype of the NCI-60 cell lines. J Transl Med 3:11","journal-title":"J Transl Med"},{"key":"499_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35932-3","volume":"14","author":"W Arif","year":"2023","unstructured":"Arif W, Mathur B, Saikali MF, Chembazhi UV, Toohill K, Song YJ, Hao Q, Karimi S, Blue SM, Yee BA et al (2023) Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death. Nat Commun 14:551","journal-title":"Nat Commun"},{"key":"499_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36826-0","volume":"14","author":"W Barczak","year":"2023","unstructured":"Barczak W, Carr SM, Liu G, Munro S, Nicastri A, Lee LN, Hutchings C, Ternette N, Klenerman P, Kanapin A et al (2023) Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nat Commun 14:1078","journal-title":"Nat Commun"},{"key":"499_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02771-9","volume":"11","author":"W Barczak","year":"2020","unstructured":"Barczak W, Jin L, Carr SM, Munro S, Ward S, Kanapin A, Samsonova A, La Thangue NB (2020) PRMT5 promotes cancer cell migration and invasion through the E2F pathway. Cell Death Dis 11:572","journal-title":"Cell Death Dis"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/1878-0261.13702","volume":"19","author":"LT Bate-Eya","year":"2025","unstructured":"Bate-Eya LT, Albayrak G, Carr SM, Shrestha A, Kanapin A, Samsonova A, La Thangue NB (2025) Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma. Mol Oncol 19:741\u2013763","journal-title":"Mol Oncol"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","volume":"178","author":"JL Benci","year":"2019","unstructured":"Benci JL, Johnson LR, Choa R, Xu Y, Qiu J, Zhou Z, Xu B, Ye D, Nathanson KL, June CH et al (2019) Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade. Cell 178:933\u2013948.e914","journal-title":"Cell"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1073\/pnas.74.8.3171","volume":"74","author":"SM Berget","year":"1977","unstructured":"Berget SM, Moore C, Sharp PA (1977) Spliced segments at the 5\u2019 terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA 74:3171\u20133175","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1101\/gad.219899.113","volume":"27","author":"M Bezzi","year":"2013","unstructured":"Bezzi M, Teo SX, Muller J, Mok WC, Sahu SK, Vardy LA, Bonday ZQ, Guccione E (2013) Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery. Genes Dev 27:1903\u20131916","journal-title":"Genes Dev"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/S1355838200992318","volume":"6","author":"M Bonin","year":"2000","unstructured":"Bonin M, Oberstrass J, Lukacs N, Ewert K, Oesterschulze E, Kassing R, Nellen W (2000) Determination of preferential binding sites for anti-dsRNA antibodies on double-stranded RNA by scanning force microscopy. RNA 6:563\u2013570","journal-title":"RNA"},{"key":"499_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67414-z","volume":"17","author":"C Bou-Nader","year":"2025","unstructured":"Bou-Nader C, Juma KM, Bothra A, Brasington AJ, Ghirlando R, Suzuki M, Garboczi DN, Leppla SH, Zhang J (2025) Structural basis of double-stranded RNA recognition by the J2 monoclonal antibody. Nat Commun 17:635","journal-title":"Nat Commun"},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","volume":"72","author":"A Calcinotto","year":"2012","unstructured":"Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, Cova A, Canese R, Jachetti E, Rossetti M et al (2012) Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res 72:2746\u20132756","journal-title":"Cancer Res"},{"key":"499_CR13","doi-asserted-by":"crossref","unstructured":"Carr SM, Liu G, Barczak W, Syffudin H, Munro S, Reyna-Jeldes D, Vendrell I, Kessler B, Cribbs AP, Kanapin A et al (2026) Separate transcription and splicing gene networks are linked and coordinated by the pRb-E2F pathway. Nucleic Acids Res 54:gkag016","DOI":"10.1093\/nar\/gkag016"},{"key":"499_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55908-9","volume":"16","author":"A Carre","year":"2025","unstructured":"Carre A, Samassa F, Zhou Z, Perez-Hernandez J, Lekka C, Manganaro A, Oshima M, Liao H, Parker R, Nicastri A et al (2025) Interferon-alpha promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic beta-cells. Nat Commun 16:765","journal-title":"Nat Commun"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","volume":"23","author":"YG Chen","year":"2022","unstructured":"Chen YG, Hur S (2022) Cellular origins of dsRNA, their recognition and consequences. Nat Rev Mol Cell Biol 23:286\u2013301","journal-title":"Nat Rev Mol Cell Biol"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2017.05.022","volume":"67","author":"YG Chen","year":"2017","unstructured":"Chen YG, Kim MV, Chen X, Batista PJ, Aoyama S, Wilusz JE, Iwasaki A, Chang HY (2017) Sensing self and foreign circular RNAs by intron identity. Mol Cell 67:228\u2013238.e225","journal-title":"Mol Cell"},{"key":"499_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14968-9","volume":"11","author":"C Chong","year":"2020","unstructured":"Chong C, Muller M, Pak H, Harnett D, Huber F, Grun D, Leleu M, Auger A, Arnaud M, Stevenson BJ et al (2020) Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat Commun 11:1293","journal-title":"Nat Commun"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","volume":"20","author":"H Climente-Gonzalez","year":"2017","unstructured":"Climente-Gonzalez H, Porta-Pardo E, Godzik A, Eyras E (2017) The functional impact of alternative splicing in cancer. Cell Rep 20:2215\u20132226","journal-title":"Cell Rep"},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molcel.2023.11.033","volume":"84","author":"KA Cottrell","year":"2024","unstructured":"Cottrell KA, Andrews RJ, Bass BL (2024) The competitive landscape of the dsRNA world. Mol Cell 84:107\u2013119","journal-title":"Mol Cell"},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14:1188\u20131190","journal-title":"Genome Res"},{"key":"499_CR21","doi-asserted-by":"crossref","unstructured":"Dausset J (1958) Iso-leuco-anticorps. Acta Haematologica 20:156\u2013166","DOI":"10.1159\/000205478"},{"key":"499_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2026.103145","volume":"147","author":"IH de Cordoba Sanchez","year":"2026","unstructured":"de Cordoba Sanchez IH, Ruidiaz MA, Moreno V, Long H, Cejas P (2026) Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors. Cancer Treat Rev 147:103145","journal-title":"Cancer Treat Rev"},{"key":"499_CR23","doi-asserted-by":"publisher","first-page":"19114","DOI":"10.1073\/pnas.1009669107","volume":"107","author":"X Deng","year":"2010","unstructured":"Deng X, Gu L, Liu C, Lu T, Lu F, Lu Z, Cui P, Pei Y, Wang B, Hu S, Cao X (2010) Arginine methylation mediated by the Arabidopsis homolog of PRMT5 is essential for proper pre-mRNA splicing. Proc Natl Acad Sci USA 107:19114\u201319119","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41420-024-02185-y","volume":"10","author":"X Deng","year":"2024","unstructured":"Deng X, Yu YV, Jin YN (2024) Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m(6)A-modification, and circular RNAs. Cell Death Discov 10:412","journal-title":"Cell Death Discov"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"8841","DOI":"10.1073\/pnas.92.19.8841","volume":"92","author":"SD Der","year":"1995","unstructured":"Der SD, Lau AS (1995) Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci USA 92:8841\u20138845","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR26","doi-asserted-by":"crossref","unstructured":"Deutsch EW, Kok LW, Mudge JM, Valls CF, Jungreis I, Ruiz-Orera J, Sun Z, Kusebauch U, Fierro-Monti I, Abelin JG et al (2026) Expanding the human proteome with microproteins and peptideins. Nature 654:813\u2013825","DOI":"10.1038\/s41586-026-10459-x"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"499_CR28","volume":"6","author":"C Dong","year":"2022","unstructured":"Dong C, Reiter JL, Dong E, Wang Y, Lee KP, Lu X, Liu Y (2022) Intron-retention neoantigen load predicts favorable prognosis in pancreatic cancer. JCO Clin Cancer Inf 6:e2100124","journal-title":"JCO Clin Cancer Inf"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1038\/s41388-021-02005-y","volume":"40","author":"CP Dong","year":"2021","unstructured":"Dong CP, Cesarano A, Bombaci G, Reiter JL, Yu CY, Wang Y, Jiang ZY, Abu Zaid M, Huang K, Lu XB et al (2021) Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma. Oncogene 40:6130\u20136138","journal-title":"Oncogene"},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.4161\/rna.8.5.16016","volume":"8","author":"M Dutertre","year":"2011","unstructured":"Dutertre M, Sanchez G, Barbier J, Corcos L, Auboeuf D (2011) The emerging role of pre-messenger RNA splicing in stress responses: sending alternative messages and silent messengers. RNA Biol 8:740\u2013747","journal-title":"RNA Biol"},{"key":"499_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0168-9","volume":"7","author":"H Dvinge","year":"2015","unstructured":"Dvinge H, Bradley RK (2015) Widespread intron retention diversifies most cancer transcriptomes. Genome Med 7:45","journal-title":"Genome Med"},{"key":"499_CR32","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/cdd.2012.22","volume":"19","author":"Y Estornes","year":"2012","unstructured":"Estornes Y, Toscano F, Virard F, Jacquemin G, Pierrot A, Vanbervliet B, Bonnin M, Lalaoui N, Mercier-Gouy P, Pacheco Y et al (2012) dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ 19:1482\u20131494","journal-title":"Cell Death Differ"},{"key":"499_CR33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027\u20131034","journal-title":"J Exp Med"},{"key":"499_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41388-024-03264-1","volume":"44","author":"MS Gillespie","year":"2025","unstructured":"Gillespie MS, Chiang K, Regan-Mochrie GL, Choi SY, Ward CM, Sahay D, Garcia P, Arnold R, Davies CC (2025) PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells. Oncogene 44:862\u2013876","journal-title":"Oncogene"},{"key":"499_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo W, Schafer S, Greaser ML, Radke MH, Liss M, Govindarajan T, Maatz H, Schulz H, Li S, Parrish AM et al (2012) RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 18:766\u2013773","journal-title":"Nat Med"},{"key":"499_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/scdb.1996.0127","volume":"8","author":"ML Hammarskjold","year":"1997","unstructured":"Hammarskjold ML (1997) Regulation of retroviral RNA export. Semin Cell Dev Biol 8:83\u201390","journal-title":"Semin Cell Dev Biol"},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526\u20131529","journal-title":"Science"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/322836a0","volume":"322","author":"JS Heilig","year":"1986","unstructured":"Heilig JS, Tonegawa S (1986) Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature 322:836\u2013840","journal-title":"Nature"},{"key":"499_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1437774","volume":"15","author":"P Huang","year":"2024","unstructured":"Huang P, Wen F, Tuerhong N, Yang Y, Li Q (2024) Neoantigens in cancer immunotherapy: focusing on alternative splicing. Front Immunol 15:1437774","journal-title":"Front Immunol"},{"key":"499_CR40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00439-017-1791-x","volume":"136","author":"AG Jacob","year":"2017","unstructured":"Jacob AG, Smith CWJ (2017) Intron retention as a component of regulated gene expression programs. Hum Genet 136:1043\u20131057","journal-title":"Hum Genet"},{"key":"499_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101\u2013105","journal-title":"Nature"},{"key":"499_CR42","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1101\/gad.305250.117","volume":"31","author":"MG Kearse","year":"2017","unstructured":"Kearse MG, Wilusz JE (2017) Non-AUG translation: a new start for protein synthesis in eukaryotes. Genes Dev 31:1717\u20131731","journal-title":"Genes Dev"},{"key":"499_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tig.2024.09.003","volume":"41","author":"E Kina","year":"2025","unstructured":"Kina E, Larouche JD, Thibault P, Perreault C (2025) The cryptic immunopeptidome in health and disease. Trends Genet 41:162\u2013169","journal-title":"Trends Genet"},{"key":"499_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","volume":"44","author":"M Kozak","year":"1986","unstructured":"Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283\u2013292","journal-title":"Cell"},{"key":"499_CR45","doi-asserted-by":"crossref","unstructured":"Kwok DW, Stevers NO, Etxeberria I, Nejo T, Cove MC, Chen LH, Jung J, Okada K, Lakshmanachetty S, Gallus M et al (2025) Tumour-wide RNA splicing aberrations generate actionable public neoantigens. Nature 639:463\u2013473","DOI":"10.1038\/s41586-024-08552-0"},{"key":"499_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51363-0","volume":"15","author":"V Lopez-Polo","year":"2024","unstructured":"Lopez-Polo V, Maus M, Zacharioudakis E, Lafarga M, Attolini CS, Marques FDM, Kovatcheva M, Gavathiotis E, Serrano M (2024) Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells. Nat Commun 15:7378","journal-title":"Nat Commun"},{"key":"499_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-7188-6-26","volume":"6","author":"R Lorenz","year":"2011","unstructured":"Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6:26","journal-title":"Algorithms Mol Biol"},{"key":"499_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","volume":"171","author":"AB Lyons","year":"1994","unstructured":"Lyons AB, Parish CR (1994) Determination of lymphocyte division by flow cytometry. J Immunol Methods 171:131\u2013137","journal-title":"J Immunol Methods"},{"key":"499_CR49","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.15252\/embj.201488726","volume":"33","author":"AK Mankan","year":"2014","unstructured":"Mankan AK, Schmidt T, Chauhan D, Goldeck M, Honing K, Gaidt M, Kubarenko AV, Andreeva L, Hopfner KP, Hornung V (2014) Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. EMBO J 33:2937\u20132946","journal-title":"EMBO J"},{"key":"499_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/npjgenmed.2016.20","volume":"1","author":"D Memon","year":"2016","unstructured":"Memon D, Dawson K, Smowton CS, Xing W, Dive C, Miller CJ (2016) Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response. NPJ Genom Med 1:16020","journal-title":"NPJ Genom Med"},{"key":"499_CR51","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1365-313X.2004.02172.x","volume":"39","author":"H Ner-Gaon","year":"2004","unstructured":"Ner-Gaon H, Halachmi R, Savaldi-Goldstein S, Rubin E, Ophir R, Fluhr R (2004) Intron retention is a major phenomenon in alternative splicing in Arabidopsis. Plant J 39:877\u2013885","journal-title":"Plant J"},{"key":"499_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature08909","volume":"463","author":"TW Nilsen","year":"2010","unstructured":"Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457\u2013463","journal-title":"Nature"},{"key":"499_CR53","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.trecan.2025.08.013","volume":"11","author":"SO Oseni","year":"2025","unstructured":"Oseni SO, Wang Y, Hwu P (2025) Advancing human leukocyte antigen-based cancer immunotherapy: from personalized to broad-spectrum strategies for genetically heterogeneous populations. Trends Cancer 11:934\u2013965","journal-title":"Trends Cancer"},{"key":"499_CR54","first-page":"4642","volume":"11","author":"J Ouyang","year":"2021","unstructured":"Ouyang J, Zhang Y, Xiong F, Zhang S, Gong Z, Yan Q, He Y, Wei F, Zhang W, Zhou M et al (2021) The role of alternative splicing in human cancer progression. Am J Cancer Res 11:4642\u20134667","journal-title":"Am J Cancer Res"},{"key":"499_CR55","doi-asserted-by":"crossref","unstructured":"Pabis K, Barardo D, Sirbu O, Selvarajoo K, Gruber J, Kennedy BK (2024) A concerted increase in readthrough and intron retention drives transposon expression during aging and senescence. eLife 12:RP87811","DOI":"10.7554\/eLife.87811"},{"key":"499_CR56","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413\u20131415","journal-title":"Nat Genet"},{"key":"499_CR57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221116120","volume":"120","author":"Y Pan","year":"2023","unstructured":"Pan Y, Phillips JW, Zhang BD, Noguchi M, Kutschera E, McLaughlin J, Nesterenko PA, Mao Z, Bangayan NJ, Wang R et al (2023) IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proc Natl Acad Sci USA 120:e2221116120","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1101\/SQB.1964.029.01.031","volume":"29","author":"R Payne","year":"1964","unstructured":"Payne R, Tripp M, Weigle J, Bodmer W, Bodmer J (1964) A new leukocyte isoantigen system in man. Cold Spring Harb Symp Quant Biol 29:285\u2013295","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"499_CR59","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M (2020) NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res 48:W449\u2013W454","journal-title":"Nucleic Acids Res"},{"key":"499_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.trecan.2024.10.008","volume":"11","author":"A Rosenberg-Mogilevsky","year":"2025","unstructured":"Rosenberg-Mogilevsky A, Siegfried Z, Karni R (2025) Generation of tumor neoantigens by RNA splicing perturbation. Trends Cancer 11:12\u201324","journal-title":"Trends Cancer"},{"key":"499_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw4640","volume":"5","author":"AP Roworth","year":"2019","unstructured":"Roworth AP, Carr SM, Liu G, Barczak W, Miller RL, Munro S, Kanapin A, Samsonova A, La Thangue NB (2019) Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control. Sci Adv 5:eaaw4640","journal-title":"Sci Adv"},{"key":"499_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21204-5","volume":"12","author":"P Sachamitr","year":"2021","unstructured":"Sachamitr P, Ho JC, Ciamponi FE, Ba-Alawi W, Coutinho FJ, Guilhamon P, Kushida MM, Cavalli FMG, Lee L, Rastegar N et al (2021) PRMT5 inhibition disrupts splicing and stemness in glioblastoma. Nat Commun 12:979","journal-title":"Nat Commun"},{"key":"499_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102506","volume":"6","author":"S Sagie","year":"2025","unstructured":"Sagie S, Babu T, Weller C, Tabachnik C, Livneh I, Quast NP, Gumpert N, Shomuradova A, Raybould MI, Levy R et al (2025) Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation. Cell Rep Med 6:102506","journal-title":"Cell Rep Med"},{"key":"499_CR64","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0002-9440(10)61693-8","volume":"159","author":"AL Scarim","year":"2001","unstructured":"Scarim AL, Arnush M, Blair LA, Concepcion J, Heitmeier MR, Scheuner D, Kaufman RJ, Ryerse J, Buller RM, Corbett JA (2001) Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol 159:273\u2013283","journal-title":"Am J Pathol"},{"key":"499_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01593-1","volume":"24","author":"JS Shah","year":"2022","unstructured":"Shah JS, Milevskiy MJG, Petrova V, Au AYM, Wong JJL, Visvader JE, Schmitz U, Rasko JEJ (2022) Towards resolution of the intron retention paradox in breast cancer. Breast Cancer Res 24:100","journal-title":"Breast Cancer Res"},{"key":"499_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50738-4","volume":"9","author":"L Shen","year":"2019","unstructured":"Shen L, Zhang J, Lee H, Batista MT, Johnston SA (2019) RNA transcription and splicing errors as a source of cancer frameshift neoantigens for vaccines. Sci Rep 9:14184","journal-title":"Sci Rep"},{"key":"499_CR67","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, Zhou Q, Xing Y (2014) rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA 111:E5593\u2013E5601","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.191","volume":"3","author":"W Shen","year":"2024","unstructured":"Shen W, Sipos B, Zhao L (2024) SeqKit2: a Swiss army knife for sequence and alignment processing. Imeta 3:e191","journal-title":"Imeta"},{"key":"499_CR69","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nbt.4239","volume":"36","author":"AC Smart","year":"2018","unstructured":"Smart AC, Margolis CA, Pimentel H, He MX, Miao D, Adeegbe D, Fugmann T, Wong KK, Van Allen EM (2018) Intron retention is a source of neoepitopes in cancer. Nat Biotechnol 36:1056\u20131058","journal-title":"Nat Biotechnol"},{"key":"499_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100410","volume":"21","author":"A Tailor","year":"2022","unstructured":"Tailor A, Estephan H, Parker R, Woodhouse I, Abdulghani M, Nicastri A, Jones K, Salatino S, Muschel R, Humphrey T et al (2022) Ionizing radiation drives key regulators of antigen presentation and a global expansion of the immunopeptidome. Mol Cell Proteom 21:100410","journal-title":"Mol Cell Proteom"},{"key":"499_CR71","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1101\/gr.220962.117","volume":"27","author":"J Tapial","year":"2017","unstructured":"Tapial J, Ha KCH, Sterne-Weiler T, Gohr A, Braunschweig U, Hermoso-Pulido A, Quesnel-Vallieres M, Permanyer J, Sodaei R, Marquez Y et al (2017) An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms. Genome Res 27:1759\u20131768","journal-title":"Genome Res"},{"key":"499_CR72","doi-asserted-by":"publisher","first-page":"e113380","DOI":"10.1371\/journal.pone.0113380","volume":"9","author":"E Trotta","year":"2014","unstructured":"Trotta E (2014) On the normalization of the minimum free energy of RNAs by sequence length. PLoS ONE 9:e113380","journal-title":"PLoS ONE"},{"key":"499_CR73","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molcel.2019.09.017","volume":"76","author":"J Ule","year":"2019","unstructured":"Ule J, Blencowe BJ (2019) Alternative splicing regulatory networks: functions, mechanisms, and evolution. Mol Cell 76:329\u2013345","journal-title":"Mol Cell"},{"key":"499_CR74","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1158\/0008-5472.CAN-08-1769","volume":"68","author":"JP Venables","year":"2008","unstructured":"Venables JP, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Koh C, Gervais-Bird J, Lapointe E, Froehlich U, Durand M et al (2008) Identification of alternative splicing markers for breast cancer. Cancer Res 68:9525\u20139531","journal-title":"Cancer Res"},{"key":"499_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1743-422X-10-349","volume":"10","author":"GM Warimwe","year":"2013","unstructured":"Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A et al (2013) Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice. Virol J 10:349","journal-title":"Virol J"},{"key":"499_CR76","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1128\/JVI.80.10.5059-5064.2006","volume":"80","author":"F Weber","year":"2006","unstructured":"Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR (2006) Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80:5059\u20135064","journal-title":"J Virol"},{"key":"499_CR77","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","volume":"20","author":"K Yang","year":"2023","unstructured":"Yang K, Halima A, Chan TA (2023) Antigen presentation in cancer\u2014mechanisms and clinical implications for immunotherapy. Nat Rev Clin Oncol 20:604\u2013623","journal-title":"Nat Rev Clin Oncol"},{"key":"499_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13276","volume":"19","author":"J Yao","year":"2020","unstructured":"Yao J, Ding D, Li X, Shen T, Fu H, Zhong H, Wei G, Ni T (2020) Prevalent intron retention fine-tunes gene expression and contributes to cellular senescence. Aging Cell 19:e13276","journal-title":"Aging Cell"},{"key":"499_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107713","volume":"215","author":"C Yong","year":"2025","unstructured":"Yong C, Liang Y, Wang M, Jin W, Fan X, Wang Z, Cao K, Wu T, Li Q, Chang C (2025) Alternative splicing: a key regulator in T cell response and cancer immunotherapy. Pharm Res 215:107713","journal-title":"Pharm Res"},{"key":"499_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-2-r14","volume":"11","author":"MD Young","year":"2010","unstructured":"Young MD, Wakefield MJ, Smyth GK, Oshlack A (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11:R14","journal-title":"Genome Biol"},{"key":"499_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15815-7","volume":"11","author":"D Zhang","year":"2020","unstructured":"Zhang D, Hu Q, Liu X, Ji Y, Chao HP, Liu Y, Tracz A, Kirk J, Buonamici S, Zhu P et al (2020) Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nat Commun 11:2089","journal-title":"Nat Commun"},{"key":"499_CR83","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.1038\/s41388-019-0910-7","volume":"38","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yan L, Zeng J, Zhou H, Liu H, Yu G, Yao W, Chen K, Ye Z, Xu H (2019) Pan-cancer analysis of clinical relevance of alternative splicing events in 31 human cancers. Oncogene 38:6678\u20136695","journal-title":"Oncogene"},{"key":"499_CR84","doi-asserted-by":"publisher","first-page":"D1340","DOI":"10.1093\/nar\/gkab851","volume":"50","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yao X, Zhou H, Wu X, Tian J, Zeng J, Yan L, Duan C, Liu H, Li H et al (2022a) OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers. Nucleic Acids Res 50:D1340\u2013D1347","journal-title":"Nucleic Acids Res"},{"key":"499_CR85","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123338119","volume":"119","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang LS, Dai Q, Chen P, Lu M, Kairis EL, Murugaiah V, Xu J, Shukla RK, Liang X et al (2022b) 5-methylcytosine (m(5)C) RNA modification controls the innate immune response to virus infection by regulating type I interferons. Proc Natl Acad Sci USA 119:e2123338119","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR86","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.molcel.2024.05.004","volume":"84","author":"R Zheng","year":"2024","unstructured":"Zheng R, Dunlap M, Bobkov GOM, Gonzalez-Figueroa C, Patel KJ, Lyu J, Harvey SE, Chan TW, Quinones-Valdez G, Choudhury M et al (2024) hnRNPM protects against the dsRNA-mediated interferon response by repressing LINE-associated cryptic splicing. Mol Cell 84:2087\u20132103.e2088","journal-title":"Mol Cell"},{"key":"499_CR87","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1261\/rna.7150804","volume":"10","author":"X Zheng","year":"2004","unstructured":"Zheng X, Bevilacqua PC (2004) Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA 10:1934\u20131945","journal-title":"RNA"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00499-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:53Z","timestamp":1789021913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00499-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":86,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00499-1","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}